TCRT today
$1.63+$0.01 (+0.62%)close Nov 13, 2026Trend
DailyUptrend (starting)
4 hourSymmetric Triangle
1 hourLeaning Bullish
15 minBullish
5 minStrong Bearish
Daily trend turns down below $0.72
Key levels
Resistance$2.19
Resistance$1.80
Support$1.31
Support$0.72
Latest news & SEC filings
AnalystTD Cowen starts Alaunos Therapeutics coverage with Buy rating
SEC FilingAlaunos Therapeutics, Inc. filed a shelf registration for future offerings (Form S-3)
SEC FilingAlaunos Therapeutics, Inc. filed a report on a major company event (Form 8-K)
All TCRT news →About Alaunos Therapeutics
Alaunos Therapeutics is a preclinical-stage biopharmaceutical company working on pill-based, non-hormonal treatments for obesity and related metabolic conditions, including metabolic dysfunction-associated steatotic liver disease. Its lead candidate is ALN1003. The company previously developed T-cell receptor engineered cell therapies for solid tumors before discontinuing that work. It has no internal manufacturing and depends on outside contractors.
Based on the company's 10-K filed Mar 31, 2026.
Nasdaq · Healthcare
Alaunos Therapeutics, Inc. (TCRT)
What Is the Price Target for TCRT?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is TCRT a Buy or Sell Right Now?
Thesis
- •Revenue growing -50.0% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for TCRT.
Start Free Trial →Is TCRT Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/B
Fair Value
$0.69
25
Moat Score
NONE
2/9
Piotroski Score
-438.1
Altman Z-Score
What Is Smart Money Doing with TCRT?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Jerman Michael Allen | director | Buy | 20,990 | $16K | Oct 6, 2026 |
| Vieser Jaime | director | Buy | 22,669 | $17K | Oct 6, 2026 |
| Weis Holger | officer | Buy | 23,564 | $18K | Oct 6, 2026 |
| Postma Robert W | director | Buy | 21,829 | $16K | Oct 6, 2026 |
| Weis Holger | officer | Buy | 3,700 | $9K | May 22, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →TCRT Growth Story
Revenue YoY
-50.0%
3yr Revenue CAGR
-88.0%
EPS Growth YoY
24.66%
FCF Growth YoY
40.3%
Revenue Trend
ACCELERATING
Dark Pool Trades for TCRT
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for TCRT, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 15:30:24 | $1.60 | 3,500 | $$6K | SELL |
| 15:24:59 | $1.64 | 1,000 | $$2K | BUY |
| 14:30:57 | $1.63 | 2,100 | $$3K | SELL |
| 14:25:00 | $1.75 | 1,900 | $$3K | BUY |
| 17:15:26 | $1.64 | 2,000 | $$3K | SELL |
5 dark pool trades shown · $$17K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Alaunos Therapeutics, Inc. (TCRT) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →TCRT — frequently asked questions
What is TCRT stock price today?
Alaunos Therapeutics, Inc. (TCRT) is at $1.63, up 0.62% (+$0.01) at the Nov 13, 2026 close.
Why is TCRT stock moving today?
Latest TCRT news — Nov 13, 2026: TD Cowen starts Alaunos Therapeutics coverage with Buy rating · Nov 12, 2026: Alaunos Therapeutics, Inc. filed a shelf registration for future offerings (Form S-3)
Did TCRT beat earnings?
TCRT last reported on Aug 13, 2026: EPS -$0.41.
Does TCRT pay a dividend?
TCRT does not currently pay a dividend.
What are TCRT support and resistance levels?
Support: $1.31, $0.72. Resistance: $1.80, $2.19, $2.67.
What are insiders doing with TCRT?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on TCRT?
Nov 13, 2026: TD Cowen starts Alaunos Therapeutics coverage with Buy rating · Nov 12, 2026: Alaunos Therapeutics, Inc. filed a shelf registration for future offerings (Form S-3) · Oct 23, 2026: Alaunos Therapeutics, Inc. filed a report on a major company event (Form 8-K)